Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis.

MLA

Ning, C., et al. “Complement Activation Promotes Colitis-Associated Carcinogenesis through Activating Intestinal IL-1β/IL-17A Axis.” Mucosal Immunology (1933-0219), vol. 8, no. 6, Nov. 2015, pp. 1275–84. EBSCOhost, https://doi.org/10.1038/mi.2015.18.

APA

Ning, C., Li, Y.-Y., Wang, Y., Han, G.-C., Wang, R.-X., Xiao, H., Li, X.-Y., Hou, C.-M., Ma, Y.-F., Sheng, D.-S., Shen, B.-F., Feng, J.-N., Guo, R.-F., Li, Y., & Chen, G.-J. (2015). Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis. Mucosal Immunology (1933-0219), 8(6), 1275–1284. https://doi.org/10.1038/mi.2015.18

Chicago

Ning, C, Y-Y Li, Y Wang, G-C Han, R-X Wang, H Xiao, X-Y Li, et al. 2015. “Complement Activation Promotes Colitis-Associated Carcinogenesis through Activating Intestinal IL-1β/IL-17A Axis.” Mucosal Immunology (1933-0219) 8 (6): 1275–84. doi:10.1038/mi.2015.18.